HomeNewsBusinessEconomy5 factors that led to a rise of corporate profit to GDP ratio to a 10-year high

5 factors that led to a rise of corporate profit to GDP ratio to a 10-year high

The share of corporate profit in India’s gross domestic product (GDP) hit a 10-year high of 2.69% in the last financial year.

June 01, 2021 / 20:12 IST
Story continues below Advertisement

The combined net profit of listed companies that declared their results by last weekend rose by 57.6% to Rs 5.11 lakh crore in 2020-21. As a result, the share of corporate profit in India’s gross domestic product (GDP) hit a 10-year high of 2.69% in the last financial year.

According to an analysis of corporate performance vis-à-vis the GDP since the global financial and economic crisis of 2008-09 in the Business Standard newspaper, the ratio was at a record low of 1.6% in 2019-20 while it was the highest in 2010-11 at 3.2%.

Story continues below Advertisement

The ratio of corporate revenue to GDP was estimated at 34.4% in 2020-21, an improvement from 33.6% in the preceding year but lower compared to 35.7% in 2018-19. The ratios were calculated for a sample of 1,054 companies that had declared their results for the financial year 2020-21 or calendar year 2020 by the last weekend. These ratios may change when the results of more listed companies are available.

Here’s a look at factors that contributed to the rise of corporate profit to GDP ratio to its highest in 10 years, even as their sales revenue growth contracted in the first two quarters and barely grew in third.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show